Table 3:
Laboratory values, drug use and comorbidities of patients with chronic kidney disease
| Variable | No. (%) of patients* n = 1859 |
|---|---|
| Laboratory values, mean ± SD | |
| Glycated hemoglobin concentration | 8.3 ± 2.3 |
| Low-density lipoprotein cholesterol level, mmol/L | 2.1 ± 0.6 |
| Drug use | |
| Statin | 980 (52.7) |
| Angiotensin-converting-enzyme inhibitor or angiotensin receptor blocker | 619 (33.3) |
| Comorbidities | |
| Diabetes mellitus | 1332 (71.6) |
| Dyslipidemia | 1313 (70.6) |
| Hypertension | 1098 (59.1) |
| 2 comorbidities† | |
| Diabetes + dyslipidemia | 1069 (57.5) |
| Diabetes + hypertension | 877 (47.2) |
| Hypertension + dyslipidemia | 852 (45.8) |
| 3 comorbidities† | |
| Hypertension + diabetes + dyslipidemia | 716 (38.5) |
Note: SD = standard deviation.
Except where noted otherwise.
Some patients are represented in more than 1 group.